公司概覽
業務類別 Biotechnology
業務概覽 Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
公司地址 1920 McKinney Avenue, 7th Floor, Dallas, TX, USA, 75201
電話號碼 +1 972 277-1136
傳真號碼 --
公司網頁 https://www.lanternpharma.com
員工數量 24
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Panna L. Sharma Chief Executive Officer, President and Director 美元 575.00K 08/08/2025
Mr. David R. Margrave Principal Accounting Officer, Chief Financial Officer and Secretary 美元 413.80K 08/08/2025
Dr. Kishor G. Bhatia, PhD Chief Scientific Officer 美元 316.00K 08/08/2025
 
董事會成員
董事會 職務 更新日期
Mr. Panna L. Sharma Chief Executive Officer, President and Director 08/08/2025
Dr. Vijay Chandru Independent Director 08/08/2025
Mr. Donald Jeffrey Keyser Chairman of the Board 08/08/2025
Mr. David S. Silberstein Independent Director 08/08/2025
Mr. Lee T. Schalop, M.D. Director 29/07/2025
Dr. Maria Maccecchini, PhD Independent Director 08/08/2025
 
所屬ETF (更新日期: 07/03/2026 03:07)
代號 名稱 佔比% 持有日期
IWCiShares Micro-Cap ETF0.19%28/02/2026
DFSUDimensional US Sustainability Core 1 ETF0.02%27/02/2026
DFACDimensional US Core Equity 2 ETF0.01%27/02/2026
DCORDimensional US Core Equity 1 ETF0.00004%27/02/2026
DXUVDimensional US Vector Equity ETF0.00004%27/02/2026
DFATDimensional US Targeted Value ETF<0.000001%08/09/2025
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.